In this issue of Cancers, Kelp et al. used a conditional Pten loss-of-function mouse model of endometrial cancer to demonstrate that Pgrmc2 deficiency attenuated the development of endometrial hyperplasia and cancer and prolonged survival. The gene discussed is PTEN; the disease is cancer.